Category: News

The hum of traffic, the open road stretching ahead – it’s a quintessential American experience. But beneath the tires, supporting that journey, lies a complex and meticulously engineered material: asphalt. Ensuring the quality of this material isn’t just about a smooth ride; it’s about safety, durability, and the responsible use of taxpayer dollars. That’s why...

The False Claims Act (FCA) has been the federal government’s most potent weapon against fraud since the Civil War. Often called “Lincoln’s Law,” it was originally designed to stop unscrupulous contractors from selling the Union Army sawdust instead of gunpowder. But as we move through 2026, the “sawdust” of the modern era isn’t a physical...

In the complex world of white-collar law enforcement, the Department of Justice (DOJ) has long played the role of the “heavy hitter,” bringing criminal charges where other agencies might only levy civil fines. However, for years, there was a glaring imbalance: while the SEC and CFTC could offer whistleblowers life-changing financial rewards, the DOJ could...

The moment an employee discovers systemic wrongdoing within their organization—whether it be financial fraud, safety violations, or environmental hazards—a ticking clock begins. This clock doesn’t just measure the time until the truth comes out; it measures the narrow window in which the employee must protect their career, their finances, and their legal standing. When a...

The case of United States et al. ex rel. Schutte et al. v. SuperValu Inc. et al, 598 U.S. 739 (2023), is not just a story of pharmacy overcharging; it is the most significant Supreme Court ruling on the False Claims Act (FCA) in a generation. The Core Dispute: What is “Usual and Customary”? The...

In the complex machinery of the American healthcare system, trust is the primary lubricant. We trust that when a doctor writes a prescription, it is necessary. We trust that when a pharmacy bills the government, it has actually provided a service. However, a landmark whistleblower case settled in late 2024 (and finalized for public record...

On January 29, 2026, the Department of Justice (DOJ) Antitrust Division did something it has never done in its decades-long history: it cut a check for $1 million to an individual whistleblower. This payment wasn’t just a reward for “doing the right thing.” It was the culmination of a high-stakes investigation into EBLOCK Corporation, an...

When the CARES Act was passed in early 2020, its primary vehicle for business support was the Paycheck Protection Program (PPP). Designed to keep employees on payroll, the program relied on “self-certification” of eligibility—a feature that saved millions of jobs but also invited unprecedented levels of fraud. As of January 16, 2026, the Department of...

Recent court rulings are changing the rules for healthcare whistleblowers, particularly in cases involving “kickbacks”. If you’ve witnessed a system designed to “nudge” doctors toward certain expensive drugs or services, a major new legal decision from 2025—United States v. Regeneron Pharmaceuticals—may impact how those cases are handled. What Happened in the Regeneron Case? The government...